Intrepid Labs is a healthcare startup focused on fast-tracking therapeutics development for improved patient outcomes. The company leverages active machine learning, advanced robotics, and extensive pharmaceutical expertise to revolutionize the design of next-generation drug products. Their unique closed-loop technology helps deliver innovation in every molecule. Intrepid Labs is a Johnson & Johnson Innovation - JLABS resident company and is involved in significant research initiatives, including collaboration with the Vector Institute’s Fast-Lane Program. The co-founders possess a wealth of experience in drug development, AI, and advanced research, positioning Intrepid Labs at the forefront of therapeutic innovation.